Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyloidosis | 2 | 2022 | 795 | 1.010 |
Why?
|
| Prothrombin Time | 1 | 2020 | 119 | 0.730 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2020 | 204 | 0.660 |
Why?
|
| International Normalized Ratio | 1 | 2020 | 367 | 0.660 |
Why?
|
| Vitamin K | 1 | 2020 | 295 | 0.630 |
Why?
|
| Hematocrit | 1 | 2019 | 636 | 0.610 |
Why?
|
| Artificial Intelligence | 6 | 2024 | 2210 | 0.600 |
Why?
|
| Thrombosis | 2 | 2023 | 2968 | 0.540 |
Why?
|
| Erythropoiesis | 1 | 2019 | 706 | 0.510 |
Why?
|
| Myocardial Revascularization | 1 | 2019 | 841 | 0.490 |
Why?
|
| Receptors, Thrombin | 1 | 2015 | 131 | 0.490 |
Why?
|
| Blood Coagulation | 1 | 2020 | 1127 | 0.490 |
Why?
|
| Venous Thrombosis | 1 | 2023 | 1240 | 0.480 |
Why?
|
| Drug Monitoring | 1 | 2020 | 953 | 0.480 |
Why?
|
| Echocardiography | 4 | 2022 | 5096 | 0.470 |
Why?
|
| Electrocardiography | 5 | 2024 | 6441 | 0.460 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2019 | 717 | 0.460 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2022 | 1265 | 0.450 |
Why?
|
| Myocytes, Cardiac | 5 | 2023 | 1631 | 0.440 |
Why?
|
| Atrial Fibrillation | 2 | 2022 | 5033 | 0.420 |
Why?
|
| Lactones | 1 | 2015 | 329 | 0.420 |
Why?
|
| Chest Pain | 1 | 2019 | 1114 | 0.400 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 1670 | 0.390 |
Why?
|
| Myocardial Infarction | 4 | 2021 | 11708 | 0.370 |
Why?
|
| Anticoagulants | 2 | 2022 | 4599 | 0.330 |
Why?
|
| Secondary Prevention | 1 | 2015 | 1529 | 0.320 |
Why?
|
| Osteopontin | 2 | 2020 | 294 | 0.310 |
Why?
|
| Membrane Lipids | 2 | 2019 | 251 | 0.310 |
Why?
|
| Phospholipids | 3 | 2023 | 784 | 0.300 |
Why?
|
| Heart | 1 | 2019 | 4460 | 0.260 |
Why?
|
| Acute Coronary Syndrome | 1 | 2019 | 2337 | 0.260 |
Why?
|
| Stroke | 2 | 2020 | 9975 | 0.260 |
Why?
|
| MicroRNAs | 1 | 2021 | 3750 | 0.250 |
Why?
|
| Kidney | 1 | 2019 | 7185 | 0.230 |
Why?
|
| Pyridines | 1 | 2015 | 2827 | 0.220 |
Why?
|
| Glutathione | 2 | 2023 | 590 | 0.210 |
Why?
|
| Hypertension | 1 | 2022 | 8480 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 11729 | 0.200 |
Why?
|
| Fatty Acids, Monounsaturated | 2 | 2019 | 194 | 0.200 |
Why?
|
| Macrophages | 3 | 2021 | 5651 | 0.190 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2021 | 1861 | 0.190 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 1 | 2021 | 56 | 0.190 |
Why?
|
| Heart Failure | 5 | 2023 | 10896 | 0.180 |
Why?
|
| Diastole | 2 | 2019 | 791 | 0.180 |
Why?
|
| Cell Hypoxia | 2 | 2020 | 675 | 0.180 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2023 | 289 | 0.170 |
Why?
|
| Adrenal Cortex | 1 | 2020 | 140 | 0.170 |
Why?
|
| Palmitic Acid | 1 | 2020 | 154 | 0.170 |
Why?
|
| Triazines | 1 | 2021 | 315 | 0.170 |
Why?
|
| Diuresis | 1 | 2019 | 116 | 0.170 |
Why?
|
| Hematology | 1 | 2022 | 221 | 0.170 |
Why?
|
| Membranes | 1 | 2018 | 173 | 0.160 |
Why?
|
| Ventricular Dysfunction | 1 | 2019 | 143 | 0.160 |
Why?
|
| Decision Making, Computer-Assisted | 1 | 2019 | 150 | 0.160 |
Why?
|
| Cardiomyopathies | 2 | 2021 | 1911 | 0.160 |
Why?
|
| STAT3 Transcription Factor | 2 | 2020 | 873 | 0.160 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2019 | 95 | 0.150 |
Why?
|
| Sirtuin 1 | 1 | 2019 | 246 | 0.150 |
Why?
|
| Predictive Value of Tests | 4 | 2023 | 15067 | 0.150 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2019 | 302 | 0.150 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2019 | 416 | 0.140 |
Why?
|
| Constriction, Pathologic | 1 | 2020 | 1108 | 0.140 |
Why?
|
| Galectin 3 | 1 | 2018 | 228 | 0.140 |
Why?
|
| Pacemaker, Artificial | 1 | 2022 | 815 | 0.140 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 494 | 0.140 |
Why?
|
| Sympathetic Nervous System | 1 | 2019 | 513 | 0.140 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 5752 | 0.140 |
Why?
|
| DNA | 2 | 2021 | 7295 | 0.140 |
Why?
|
| Cardiomegaly | 1 | 2019 | 621 | 0.140 |
Why?
|
| Video Recording | 1 | 2020 | 949 | 0.130 |
Why?
|
| Adenosine Triphosphatases | 1 | 2019 | 839 | 0.130 |
Why?
|
| Mitochondrial Proteins | 1 | 2021 | 993 | 0.130 |
Why?
|
| Stroke Volume | 3 | 2024 | 5002 | 0.130 |
Why?
|
| Atrioventricular Block | 1 | 2016 | 120 | 0.130 |
Why?
|
| Aldosterone | 1 | 2020 | 877 | 0.130 |
Why?
|
| Disease Progression | 2 | 2023 | 13273 | 0.120 |
Why?
|
| Doxorubicin | 1 | 2021 | 2234 | 0.120 |
Why?
|
| Neoplasms | 1 | 2023 | 21675 | 0.120 |
Why?
|
| Erythropoietin | 1 | 2019 | 726 | 0.120 |
Why?
|
| Dystonic Disorders | 1 | 2018 | 329 | 0.120 |
Why?
|
| Coronary Stenosis | 1 | 2020 | 833 | 0.120 |
Why?
|
| Leukemia | 1 | 2022 | 1509 | 0.120 |
Why?
|
| Heart Valve Prosthesis | 1 | 2022 | 1489 | 0.110 |
Why?
|
| Warfarin | 1 | 2022 | 1497 | 0.110 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2016 | 478 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2020 | 1524 | 0.110 |
Why?
|
| Interleukin-10 | 1 | 2018 | 1200 | 0.110 |
Why?
|
| Hemoglobins | 1 | 2019 | 1531 | 0.110 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2024 | 2074 | 0.110 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2022 | 1344 | 0.110 |
Why?
|
| Thalamus | 1 | 2018 | 1023 | 0.110 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 2029 | 0.110 |
Why?
|
| Administration, Oral | 1 | 2020 | 3912 | 0.110 |
Why?
|
| Coronary Angiography | 2 | 2023 | 4576 | 0.110 |
Why?
|
| Humans | 24 | 2024 | 743811 | 0.100 |
Why?
|
| Diabetic Nephropathies | 1 | 2019 | 984 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 1 | 2022 | 1534 | 0.100 |
Why?
|
| Monocytes | 1 | 2021 | 2593 | 0.100 |
Why?
|
| Fatty Acids | 1 | 2019 | 1809 | 0.100 |
Why?
|
| Protein Unfolding | 2 | 2021 | 54 | 0.090 |
Why?
|
| Heart Diseases | 1 | 2024 | 2789 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2023 | 17439 | 0.090 |
Why?
|
| Aortic Valve Stenosis | 1 | 2022 | 1955 | 0.090 |
Why?
|
| Mice | 9 | 2022 | 81154 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5078 | 0.080 |
Why?
|
| Hemorrhage | 1 | 2020 | 3458 | 0.080 |
Why?
|
| Time Factors | 2 | 2020 | 40038 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2018 | 2002 | 0.080 |
Why?
|
| Treatment Outcome | 4 | 2023 | 63042 | 0.070 |
Why?
|
| Glucose | 1 | 2019 | 4398 | 0.070 |
Why?
|
| Patient Selection | 1 | 2019 | 4210 | 0.070 |
Why?
|
| Membrane Proteins | 2 | 2021 | 7880 | 0.070 |
Why?
|
| Animals | 11 | 2022 | 168660 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 19894 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2021 | 13028 | 0.070 |
Why?
|
| Mutation | 2 | 2021 | 29777 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2023 | 23327 | 0.070 |
Why?
|
| Databases, Factual | 1 | 2020 | 7729 | 0.060 |
Why?
|
| Cell Death | 2 | 2021 | 1705 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 2200 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 7719 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 9440 | 0.060 |
Why?
|
| Registries | 1 | 2020 | 8090 | 0.060 |
Why?
|
| Mice, Knockout | 4 | 2021 | 14563 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2020 | 3445 | 0.060 |
Why?
|
| Cells, Cultured | 4 | 2021 | 19232 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 6485 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14714 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 12954 | 0.060 |
Why?
|
| Reperfusion | 1 | 2023 | 283 | 0.050 |
Why?
|
| Risk Factors | 4 | 2023 | 72252 | 0.050 |
Why?
|
| gamma-Glutamylcyclotransferase | 1 | 2021 | 8 | 0.050 |
Why?
|
| Phosphatidylcholines | 1 | 2023 | 410 | 0.050 |
Why?
|
| Anthracyclines | 1 | 2024 | 288 | 0.050 |
Why?
|
| Epoxy Compounds | 1 | 2022 | 136 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 21824 | 0.050 |
Why?
|
| Prognosis | 2 | 2020 | 29052 | 0.050 |
Why?
|
| Blood Cells | 1 | 2023 | 310 | 0.050 |
Why?
|
| Ventricular Function, Left | 2 | 2024 | 3660 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2024 | 13691 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 12066 | 0.050 |
Why?
|
| Rats, Inbred Dahl | 1 | 2020 | 35 | 0.050 |
Why?
|
| Sterol Esterase | 1 | 2020 | 37 | 0.050 |
Why?
|
| RING Finger Domains | 1 | 2019 | 7 | 0.050 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2020 | 63 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2024 | 690 | 0.040 |
Why?
|
| Zona Glomerulosa | 1 | 2020 | 86 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 7658 | 0.040 |
Why?
|
| Male | 8 | 2021 | 349776 | 0.040 |
Why?
|
| Catecholamines | 1 | 2020 | 387 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 57744 | 0.040 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2022 | 844 | 0.040 |
Why?
|
| Mannose-Binding Lectins | 1 | 2018 | 100 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2020 | 8436 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2020 | 23398 | 0.040 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 18027 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 233 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 15142 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 53250 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2023 | 2018 | 0.030 |
Why?
|
| Septal Occluder Device | 1 | 2016 | 128 | 0.030 |
Why?
|
| Female | 6 | 2021 | 380020 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2018 | 589 | 0.030 |
Why?
|
| Mast Cells | 1 | 2022 | 1544 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2023 | 1542 | 0.030 |
Why?
|
| Ischemia | 1 | 2023 | 1907 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2020 | 2725 | 0.030 |
Why?
|
| Rats | 2 | 2021 | 24250 | 0.030 |
Why?
|
| Phenotype | 2 | 2023 | 16361 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 1146 | 0.030 |
Why?
|
| Aged | 3 | 2020 | 163178 | 0.030 |
Why?
|
| Pedigree | 1 | 2021 | 4643 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2018 | 1539 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2022 | 1920 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 1783 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1781 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4204 | 0.030 |
Why?
|
| Ventricular Remodeling | 1 | 2019 | 1225 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2018 | 3000 | 0.020 |
Why?
|
| Triglycerides | 1 | 2018 | 2453 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 2509 | 0.020 |
Why?
|
| Cholesterol | 1 | 2020 | 2922 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 4183 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 1885 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2021 | 3082 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2020 | 5973 | 0.020 |
Why?
|
| RNA Interference | 1 | 2018 | 2890 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 3504 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 2865 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2022 | 6188 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2022 | 77410 | 0.020 |
Why?
|
| Adult | 4 | 2021 | 213889 | 0.020 |
Why?
|
| Myocardium | 1 | 2018 | 4775 | 0.020 |
Why?
|
| Cell Line | 1 | 2020 | 15993 | 0.020 |
Why?
|
| Middle Aged | 4 | 2020 | 213241 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2023 | 12259 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2023 | 15518 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2019 | 8551 | 0.010 |
Why?
|
| Young Adult | 2 | 2020 | 56392 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 13980 | 0.010 |
Why?
|
| Adolescent | 2 | 2020 | 85729 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39001 | 0.010 |
Why?
|
| Child | 1 | 2022 | 77637 | 0.010 |
Why?
|
Concepts
(203)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_